Freely Filtered 057: NephMadness 2023 TMA

1

Introduction

00:00 • 2min

2

Nef Madness: Step Away From Executive Team

02:24 • 3min

3

Is TMA a New Entity?

05:21 • 3min

4

TMA Expertise

08:06 • 2min

5

TMA in Asia? What's the Difference?

10:16 • 2min

6

Atypical HUS

12:37 • 5min

7

Nephrology Secrets - What's the Difference?

17:08 • 2min

8

Malignant Hypertension TMA

19:04 • 6min

9

Gene Sequencing Is Crucial for Nephrology

24:38 • 6min

10

Is There a Risk of ATN?

30:16 • 2min

11

Tma

31:51 • 3min

12

Do You Think We Should Talk About the Alternative Compromised Pathway?

34:30 • 2min

13

The Compliment Pathway

36:00 • 3min

14

What's the MAC Attack?

38:44 • 2min

15

Is Echolizumab a C5 Inhibitor?

40:38 • 2min

16

Is Avocopan an Oral C5 Inhibitor?

43:03 • 5min

17

Is There a Randomized Controlled Trial in Kidney Failure?

47:34 • 3min

18

Is There a Way to Enroll Rare Diseases in Clinical Trials?

51:00 • 4min

19

Is There a Specific Mutation in Preeclampsia?

55:27 • 2min

20

Transplant Question With TMA - Is There a Genetic Mutation in TMA?

57:40 • 5min

21

Is There a Role of Complement Therapy in Secondary TMA's?

01:02:27 • 3min

22

Neph Madness Primary or Secondary?

01:05:13 • 2min

23

Neph Madness Podcasts Open March 31st

01:06:45 • 2min

24

Neuromancer by Fia - I Saw the Series and Then I Saw the Series

01:08:17 • 1min

25

Nephrology Is Awesome Isn't It?

01:09:25 • 5min

26

Mentor Mentorship Through Women in Nephrology

01:14:18 • 3min

27

Mastodon Ivory by Tapbox for iOS and iPad OS

01:17:14 • 2min

28

Mastodon and Nephrology Isn't as Big as Neph Twitter

01:19:34 • 2min